Skip to main content
Equibles
IMA logo

IMA · ImageneBio, Inc. · Metrics

Track IMA — free

Use IMA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.02 -0.07 (-1.71%) At close · Nov 3
Rebalance outlook locked
Market Cap
$45.63M
Shares
11.35M
Volume · Nov 3 9065 Avg daily vol (3M) 13.65K

IMA metrics

69 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.02
Market cap
$45.63M

Price action

20 metrics
Price change (1W)
+1.0%
Price change (30D)
-13.0%
Price change (3M)
-27.5%
Price change (6M)
-28.4%
Price change (YTD)
-40.7%
Price change (1Y)
-53.0%
Trailing year
Price change (5Y)
—
52-week high
$8.61
52-week low
$4.00
Change from 52-week high
-52.5%
Change from 52-week low
+2.3%
Annualized volatility
56.9%
Annualized volatility (3M)
36.8%
Beta
0.9
RSI (14D)
40.0
Price vs SMA 50
-11.8%
Price vs SMA 200
-27.2%
Avg volume (3M)
13,574
Relative volume
0.6
Average dollar volume
$65,723

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
11.35M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
-111.2×
EV / EBITDA
—
EV / EBIT
—
P / sales
58.0×
reciprocal yield 1.7%
P / book
0.3
reciprocal yield 306.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-113.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-15

Profitability

9 metrics
Gross margin
—
Operating margin
-6,056.4%
Trailing 12 months
Net margin
-5,668.6%
Gross profit (TTM)
—
Operating profit (TTM)
−$58.96M
Net income (TTM)
−$52.48M
Trailing 12 months
Diluted EPS (TTM)
$-2.96
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
$-23.58
Capital expenditures per diluted share (TTM)
$0.13
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-44.85

Growth

11 metrics
Revenue growth YoY
-77.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$800,000
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+571.6%
Year over year · more shares
Revenue CAGR (3Y)
-62.9%
Revenue CAGR (5Y)
-38.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-36.9%
Return on assets
-34.5%
Debt / equity
0.0
Current ratio
21.5
EBITDA (TTM)
−$58.56M
Free cash flow (TTM)
—
Quick ratio
21.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$135.35M
Latest balance sheet
Cash & equivalents
$94.68M
Total assets
$152.04M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$52.59M
Capital expenditures (TTM)
$414,000
R&D (TTM)
$31.46M
SG&A (TTM)
—
Stock compensation (TTM)
$17.12M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
35
13F filer change QoQ
-4
Institutional ownership
54.9%
Conviction holders (share of 13F filers)
2.9%
Crowding (high-turnover and private-fund holders)
28.3%
Private-fund adviser ownership
28.1%
Active holders' share change QoQ
+18.3%
Holder tenure
3.5
Price vs estimated holder cost
-11.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
3.5%

Short interest

3 metrics
Short interest
0.5%
Latest settlement · 4.2 days to cover
Days to cover
4.2d
Short-squeeze score
41 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1835579 CUSIP 45175G207 13F (30d) 1 filings 1 filers Visit website Investor relations